222 related articles for article (PubMed ID: 15523318)
1. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.
Pan M; de Lezo JS; Medina A; Romero M; Segura J; Pavlovic D; Delgado A; Ojeda S; Melián F; Herrador J; Ureña I; Burgos L
Am Heart J; 2004 Nov; 148(5):857-64. PubMed ID: 15523318
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
[TBL] [Abstract][Full Text] [Related]
4. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
5. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.
Kelbaek H; Thuesen L; Helqvist S; Kløvgaard L; Jørgensen E; Aljabbari S; Saunamäki K; Krusell LR; Jensen GV; Bøtker HE; Lassen JF; Andersen HR; Thayssen P; Galløe A; van Weert A;
J Am Coll Cardiol; 2006 Jan; 47(2):449-55. PubMed ID: 16412876
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.
Hildick-Smith D; de Belder AJ; Cooter N; Curzen NP; Clayton TC; Oldroyd KG; Bennett L; Holmberg S; Cotton JM; Glennon PE; Thomas MR; Maccarthy PA; Baumbach A; Mulvihill NT; Henderson RA; Redwood SR; Starkey IR; Stables RH
Circulation; 2010 Mar; 121(10):1235-43. PubMed ID: 20194880
[TBL] [Abstract][Full Text] [Related]
11. Culotte versus T-stenting in bifurcation lesions: immediate clinical and angiographic results and midterm clinical follow-up.
Kaplan S; Barlis P; Dimopoulos K; La Manna A; Goktekin O; Galassi A; Tanigawa J; Di Mario C
Am Heart J; 2007 Aug; 154(2):336-43. PubMed ID: 17643585
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of stenting with sirolimus eluting stent and spot stenting with small vessel stent in treatment of small vessels with long lesions].
Li XM; Wang S; Li B; Wang TS; Chen GL; Wang W; Ma JL; Wang Q; Su ZT
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):265-7. PubMed ID: 17425875
[TBL] [Abstract][Full Text] [Related]
15. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
[TBL] [Abstract][Full Text] [Related]
16. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience.
Burzotta F; Gwon HC; Hahn JY; Romagnoli E; Choi JH; Trani C; Colombo A
Catheter Cardiovasc Interv; 2007 Jul; 70(1):75-82. PubMed ID: 17585382
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
[TBL] [Abstract][Full Text] [Related]
20. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
Tsuchida K; Colombo A; Lefèvre T; Oldroyd KG; Guetta V; Guagliumi G; von Scheidt W; Ruzyllo W; Hamm CW; Bressers M; Stoll HP; Wittebols K; Donohoe DJ; Serruys PW
Eur Heart J; 2007 Feb; 28(4):433-42. PubMed ID: 17267457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
